Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 58 full-time employees. The firm has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).
How did ASRT's recent EPS compare to expectations?
The most recent EPS for Assertio Holdings Inc is $-1.86, not beating expectations of $-2.76.
How did Assertio Holdings Inc ASRT's revenue perform in the last quarter?
Assertio Holdings Inc revenue for the last quarter is $-1.86
What is the revenue estimate for Assertio Holdings Inc?
According to 6 of Wall street analyst, the revenue estimate of Assertio Holdings Inc range from $36.22M to $26.01M
What's the earning quality score for Assertio Holdings Inc?
Assertio Holdings Inc has a earning quality score of B+/57.304302. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Assertio Holdings Inc report earnings?
Assertio Holdings Inc next earnings report is expected in 2026-06-14
What are Assertio Holdings Inc's expected earnings?
Assertio Holdings Inc expected earnings is $16.95M, according to wall-street analysts.
Did Assertio Holdings Inc beat earnings expectations?
Assertio Holdings Inc recent earnings of $13.54M does not beat expectations.